PCVX
Vaxcyte, Inc.
NASDAQ · Healthcare · Biotechnology · US
$63.68
+0.09%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-38.6%
Return on equity
-33.9%
Return on assets
-40.6%
Return on invested capital
0.00x
Asset turnover
-$1.2B
Cash from operations
$9.45
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026